| |
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
| EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation
Volume 8, Number 10, October 2002 Bioterrorism-Related Anthrax Laboratory Response to Anthrax Bioterrorism, New York City, 2001Michael B. Heller,* Michel L. Bunning,† Martin E.B. France,‡ Debra
M. Niemeyer,§ Leonard Peruski,¶ Tim Naimi,† Phillip M. Talboy,† Patrick
H. Murray,# Harald W. Pietz,† John Kornblum,* William Oleszko,* Sara T.
Beatrice,* Joint Microbiological Rapid Response Team,
[1] and New York City Anthrax Investigation Working Group [2] |
||
|
|
![]() |
|
| Back to article | |
|
Figure 3. Depiction of the data flow at the New York City Bioterrorism Response Laboratory adopted soon after the surge of isolates after the bioterrorism attack. An access database was developed, and a number of demographic fields and test results were identified and entered. Data retrieved from the Biosafety Level 3 (BSL-3) laboratory after suspicious packages were opened had to be input into the database; the original documentation was modified if any additional information was identified. An attempt was made to monitor all transactions occurring to the sample, which began to make the system unwieldy. The database was modified numerous times and recently was entirely replaced. Most of the comments, such as “no place in database” have been corrected. PCR, polymerase chain reaction; DOD, Department of Defense; HHA, hand-held analysis; DFA, direct fluorescent-antibody assay; OEM, Office of Emergency Management. |
|
|
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
|
This page last reviewed September 16, 2002 |
|
|
Emerging
Infectious Diseases Journal |
|